Bow Capital overview
Stories about Bow Capital
ArangoDB nabs $10 mln Series A
ArangoDB, an open source native multi-model database, has secured $10 million in Series A funding. Bow Capital led the round.
Bow Capital backs Eversight
Bow Capital has made an undisclosed investment in Eversight. Based in Palo Alto, California, Eversight is a software provider that helps retailers and consumer goods companies improve their promotions.
Bow Capital contact information
Offices
2440 Sand Hill Rd, Suite 101, Menlo Park, 94025, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. James Chan | Job titleChief Financial Officer | LocationMenlo Park, United States | Email  ------- |
| Mr. Vivek Ranadive | Job titleFounder and Managing Director | LocationMenlo Park, United States | Email ------ |
| Mr. Murray Rode | Job titleGeneral Partner | LocationMenlo Park, United States | Email ----- |
| Mr. Rafi Syed | Job titleGeneral Partner | LocationSan Francisco, United States | Email --------- |
Bow Capital funds managed
Funds in market: 1
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size ----------- | Open dateDec 2023 | Strategy --------- | |
Closed funds: 2
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ----- | Close dateOct 2016 | Strategy ----- | |
Fund size ------- | Close date- | Strategy ---------- | |
Stories that mention Bow Capital
Mothership pockets $76m
Mothership, a short-haul freight-technology company, has raised $76 million in funding.
Merit pockets $50m Series B
Merit, a verified identity platform, has raised $50 million in Series B funding.
Clearco inks $215m financing led by SoftBank’s Vision Fund 2
Toronto-based Clearco, a provider of capital solutions for e-commerce, mobile apps and software-as-a-service businesses, has raised $215 million in financing.
DataJoy nets $6m
Analytics company DataJoy has secured $6 million in funding.
Gene editing rides new investment wave
Clinical approvals are lifting confidence in gene editing and gene therapy, triggering a new wave of investment. Could this be healthcare’s new new thing?
GenEdit pulls in $8.5 mln
Berkeley, California-based GenEdit Inc, a developer of next generation therapeutics for genetic diseases, has closed $8.5 million in funding. Data Collective Bio and SK Holdings led the round with participation from other investors that included Sequoia Capital and Bow Capital.
Women's health products company Flex rakes in $3.6 mln
Venice, California-based The Flex Company, a maker of women's health products, has raised $3.6 million in funding. The investors included BOW Capital, Quest Venture Partners, Halogen Ventures and Y Combinator. Also, Flex has acquired rival Keela LLC, a maker of a menstrual cup.
Kloudless picks up $6 mln Series A
Berkeley, California-based Kloudless, an enterprise integrations solution for developer and product teams, has raised $6 million in Series A funding. Aspect Ventures led the round with participation from Bow Capital, Alibaba Taiwan Entrepreneurs Fund, Heavybit, Ajay Shah, Tim Draper and David Sacks.